Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for Elevated Heart Rate in Severe Sepsis
NCT03367026Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of ivabradine in septic shock (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: mean heart rate at 24 hours. Status: unknown.
02
Drugs
ivabradine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03367026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03367026.